← Back to Clinical Trials
Recruiting NCT04855825

NCT04855825 Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04855825
Status Recruiting
Phase
Sponsor Kessler Foundation
Condition Multiple Sclerosis
Study Type INTERVENTIONAL
Enrollment 10 participants
Start Date 2017-10-05
Primary Completion 2027-12-30

Trial Parameters

Condition Multiple Sclerosis
Sponsor Kessler Foundation
Study Type INTERVENTIONAL
Phase N/A
Enrollment 10
Sex ALL
Min Age 18 Years
Max Age 75 Years
Start Date 2017-10-05
Completion 2027-12-30
Interventions
Robotic Exoskeleton RehabilitationConventional Gait Therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The purpose of this research study is to evaluate the usefulness of a wearable robotic exoskeleton device (Ekso-GT), to improve learning and memory, and gait therapy in persons with walking disability due to Multiple Sclerosis. The study will evaluate the mobility, learning and memory, and walking abilities of individuals with multiple sclerosis who went through the traditional as compared to others who used the robotic exoskeleton as part of their therapy.

Eligibility Criteria

Inclusion Criteria: * Be diagnosed with multiple sclerosis. * Be determined by the study staff to have moderate to severe difficulty walking but still be able to walk while using the robotic exoskeleton. * Have some difficulty thinking and problem solving as determined by my performance on a special test that I will take during the screening visit. * Be between the ages of 18 and 75. * Be free from flair ups of my MS Symptoms for at least one month prior to testing. * Discuss with study staff how to maintain a constant level of my spasticity medication (for example baclofen) throughout the study. * Be able to walk (with the use of one or more assistive device if needed). * Have English as my primary language. * Be able to physically fit into the exoskeleton device: height between 60 and 76", weight under 220 lbs. * Be able to tolerate upright standing for 30 minutes with assistance if needed. * Have normal joint range of motion for walking as determined by study staff. * Have sufficien

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology